According to The Associated Press, a federal jury in San Francisco convicted Dr. W. Scott Harkonen after a seven-week trial. The conviction centered on an August 2002 news release that misstated the results of a clinical trial using Actimmune to treat the disease. The release falsely said the test showed Actimmune helped IPF patients live longer.
Treating one IPF patient with Actimmune for a year cost about $50,000, and most Actimmune sales were for the unapproved treatment of IPF, the Justice Department said.
For more information about the case, please click here.
|
Share this article with your social network, just click below to share now!
|
|
|
No comments:
Post a Comment